Devore Adam D, Mentz Robert J, Patel Chetan B
Division of Cardiology, Duke University Medical Center, 2301 Erwin Road, DUMC 3845, Durham, NC, 27710, USA,
Curr Treat Options Cardiovasc Med. 2014 Feb;16(2):283. doi: 10.1007/s11936-013-0283-0.
The prevalence of patients living with advanced heart failure continues to rise. For a subset of these patients, continuous-flow left ventricular assist devices (LVADs) are a life-saving therapy. Given the efficacy and durability of contemporary LVAD devices, their use has increased exponentially in recent years. The medical management of patients with an LVAD is an area of expertise for advanced heart failure clinicians, but a general understanding of the initial approach to, and stabilization of, LVAD patients is an important skillset for many health care providers. The rapidly changing field of the medical management of LVAD patients is largely based on clinical experience and limited published data. In this manuscript, we integrate the available published data on the medical management of LVAD patients with the growing clinical experience.
晚期心力衰竭患者的患病率持续上升。对于其中一部分患者,连续血流左心室辅助装置(LVAD)是一种挽救生命的治疗方法。鉴于当代LVAD装置的疗效和耐用性,其使用量近年来呈指数级增长。LVAD患者的医疗管理是晚期心力衰竭临床医生的专业领域,但对于许多医疗保健提供者来说,对LVAD患者的初始治疗方法和病情稳定的一般了解是一项重要技能。LVAD患者医疗管理这一快速变化的领域很大程度上基于临床经验和有限的已发表数据。在本手稿中,我们将关于LVAD患者医疗管理的现有已发表数据与不断增长的临床经验相结合。